Process View
The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "viral entry into host cell"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.999 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.999 | ||
| IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.847 | ||
| IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.814 | ||
| TRIM39 | tripartite motif containing 39 | 0.695 | Human | |
| ENG | endoglin | 0.584 | ||
| FHL2 | four and a half LIM domains 2 | 0.526 | ||
| FN1 | fibronectin 1 | 0.481 | ||
| UBE2D4 | ubiquitin-conjugating enzyme E2D 4 (putative) | 0.481 | ||
| MED15 | mediator complex subunit 15 | 0.462 | ||
| TLN1 | talin 1 | 0.341 | ||
| AXL | AXL receptor tyrosine kinase | 0.282 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.278 | ||
| IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.266 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.241 | Human | |
| TRIM43 | tripartite motif containing 43 | 0.237 | ||
| PVRL4 | poliovirus receptor-related 4 | 0.225 | ||
| PXN | paxillin | 0.202 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.134 | ||
| RNF5 | ring finger protein 5 | 0.126 | ||
| PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | 0.114 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.097 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.097 | ||
| KDM6A | lysine (K)-specific demethylase 6A | 0.092 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.090 | ||
| ZNRF1 | zinc and ring finger 1 | 0.090 | ||
| DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 0.082 | ||
| TRIM41 | tripartite motif containing 41 | 0.071 | Human | |
| NAMPT | nicotinamide phosphoribosyltransferase | 0.071 | ||
| BST2 | bone marrow stromal cell antigen 2 | 0.070 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.070 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.063 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.062 | Human | |
| FLNA | filamin A, alpha | 0.060 | ||
| ITGB4 | integrin, beta 4 | 0.060 | ||
| UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.059 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.058 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.057 | Human | |
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.056 | ||
| THBS1 | thrombospondin 1 | 0.056 | ||
| TRIM8 | tripartite motif containing 8 | 0.054 | Mouse | |
| LRSAM1 | leucine rich repeat and sterile alpha motif containing 1 | 0.052 | ||
| GCC1 | GRIP and coiled-coil domain containing 1 | 0.052 | ||
| MAGEA4 | melanoma antigen family A, 4 | 0.049 | ||
| IRF9 | interferon regulatory factor 9 | 0.046 | ||
| TRIM26 | tripartite motif containing 26 | 0.043 | ||
| RNF126 | ring finger protein 126 | 0.042 | ||
| EFCAB4B | EF-hand calcium binding domain 4B | 0.041 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.041 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.033 | ||
| ZNF473 | zinc finger protein 473 | 0.029 | ||
| IFI16 | interferon, gamma-inducible protein 16 | 0.029 | ||
| BTN3A2 | butyrophilin, subfamily 3, member A2 | 0.028 | ||
| CD63 | CD63 molecule | 0.028 | ||
| FBF1 | Fas (TNFRSF6) binding factor 1 | 0.028 | ||
| PML | promyelocytic leukemia | 0.026 | ||
| TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.026 | ||
| PLSCR1 | phospholipid scramblase 1 | 0.026 | ||
| SP110 | SP110 nuclear body protein | 0.025 | ||
| UBE2U | ubiquitin-conjugating enzyme E2U (putative) | 0.024 | ||
| IFNA16 | interferon, alpha 16 | 0.022 | Human | |
| TRIM21 | tripartite motif containing 21 | 0.021 | Human Mouse | |
| RNF11 | ring finger protein 11 | 0.021 | ||
| DYDC1 | DPY30 domain containing 1 | 0.021 | ||
| UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.020 | ||
| RNF181 | ring finger protein 181 | 0.020 | ||
| USP4 | ubiquitin specific peptidase 4 (proto-oncogene) | 0.020 | ||
| TRIM17 | tripartite motif containing 17 | 0.020 | Human | |
| TRIM52 | tripartite motif containing 52 | 0.020 | ||
| UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.018 | ||
| ABHD16A | abhydrolase domain containing 16A | 0.018 | ||
| CD9 | CD9 molecule | 0.018 | ||
| ZC3HAV1 | zinc finger CCCH-type, antiviral 1 | 0.018 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.017 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.017 | ||
| UBE2D3 | ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) | 0.016 | ||
| TRIM32 | tripartite motif containing 32 | 0.016 | ||
| COL17A1 | collagen, type XVII, alpha 1 | 0.016 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.016 | ||
| TSGA10 | testis specific, 10 | 0.015 | ||
| STX7 | syntaxin 7 | 0.015 | ||
| ADAM9 | ADAM metallopeptidase domain 9 | 0.015 | ||
| EPHA2 | EPH receptor A2 | 0.014 | ||
| TRIM35 | tripartite motif containing 35 | 0.014 | ||
| IFNA10 | interferon, alpha 10 | 0.014 | Human | |
| DDX3X | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked | 0.014 | ||
| TRIM25 | tripartite motif containing 25 | 0.014 | ||
| RNF10 | ring finger protein 10 | 0.014 | ||
| ARL6IP5 | ADP-ribosylation-like factor 6 interacting protein 5 | 0.014 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.014 | ||
| ITGB5 | integrin, beta 5 | 0.013 | ||
| PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) | 0.013 | ||
| C19orf66 | chromosome 19 open reading frame 66 | 0.013 | ||
| RNF31 | ring finger protein 31 | 0.013 | ||
| SHISA5 | shisa homolog 5 (Xenopus laevis) | 0.013 | ||
| ZBTB8A | zinc finger and BTB domain containing 8A | 0.013 | ||
| MKRN3 | makorin ring finger protein 3 | 0.013 | ||
| SH3BGRL | SH3 domain binding glutamic acid-rich protein like | 0.013 | ||
| UBTD1 | ubiquitin domain containing 1 | 0.012 | ||
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.012 | ||
| TRIM5 | tripartite motif containing 5 | 0.012 | ||
| WFDC2 | WAP four-disulfide core domain 2 | 0.012 | ||
| RNF130 | ring finger protein 130 | 0.011 | ||
| CRP | C-reactive protein, pentraxin-related | 0.011 | Human | |
| SP100 | SP100 nuclear antigen | 0.011 | ||
| RNF32 | ring finger protein 32 | 0.011 | ||
| RNF185 | ring finger protein 185 | 0.011 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.011 | ||
| TMPRSS4 | transmembrane protease, serine 4 | 0.011 | Human | |
| ANXA1 | annexin A1 | 0.011 | ||
| MCOLN1 | mucolipin 1 | 0.011 | ||
| IFNA4 | interferon, alpha 4 | 0.011 | ||
| ITGB1BP1 | integrin beta 1 binding protein 1 | 0.011 | ||
| MEX3B | mex-3 homolog B (C. elegans) | 0.011 | ||
| ITGA7 | integrin, alpha 7 | 0.011 | ||
| RNF111 | ring finger protein 111 | 0.011 | ||
| MAGEA1 | melanoma antigen family A, 1 (directs expression of antigen MZ2-E) | 0.011 | ||
| APCS | amyloid P component, serum | 0.011 | ||
| EIF1AY | eukaryotic translation initiation factor 1A, Y-linked | 0.011 | ||
| MID1 | midline 1 (Opitz/BBB syndrome) | 0.010 | Human | |
| LY6E | lymphocyte antigen 6 complex, locus E | 0.010 | ||
| TRIM6-TRIM34 | TRIM6-TRIM34 readthrough | 0.010 | ||
| BFAR | bifunctional apoptosis regulator | 0.010 | ||
| STX4 | syntaxin 4 | 0.010 | ||
| MGRN1 | mahogunin, ring finger 1 | 0.010 | ||
| LAD1 | ladinin 1 | 0.010 |